10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2017 | |||
Consolidated Statement of Earnings | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 16, 2018) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Net Sales | $ 27,390 | 20,853 | 20,405 |
| Cost of products sold, excluding amortization of intangible assets | 12,337 | 9,024 | 8,747 |
| Amortization of intangible assets | 1,975 | 550 | 601 |
| Research and development | 2,235 | 1,422 | 1,405 |
| Selling, general and administrative | 9,117 | 6,672 | 6,785 |
| Total Operating Cost and Expenses | 25,664 | 17,668 | 17,538 |
| Operating Earnings | 1,726 | 3,185 | 2,867 |
| Interest expense | 904 | 431 | 163 |
| Interest income | (124) | (99) | (105) |
| Net foreign exchange (gain) loss | (34) | 495 | (93) |
| Other (income) expense, net | (1,251) | 945 | (281) |
| Earnings from Continuing Operations Before Taxes | 2,231 | 1,413 | 3,183 |
| Taxes on Earnings from Continuing Operations | 1,878 | 350 | 577 |
| Earnings from Continuing Operations | 353 | 1,063 | 2,606 |
| Earnings from Discontinued Operations, net of taxes | 124 | 321 | 65 |
| Gain on sale of Discontinued Operations, net of taxes | 16 | 1,752 | |
| Net Earnings from Discontinued Operations, net of taxes | 124 | 337 | 1,817 |
| Net Earnings | 477 | 1,400 | 4,423 |
| Basic Earnings Per Common Share -- | |||
| Continuing Operations (in dollars per share) | 0.20 | 0.71 | 1.73 |
| Discontinued Operations (in dollars per share) | 0.07 | 0.23 | 1.21 |
| Net Earnings (in dollars per share) | 0.27 | 0.94 | 2.94 |
| Diluted Earnings Per Common Share -- | |||
| Continuing Operations (in dollars per share) | 0.20 | 0.71 | 1.72 |
| Discontinued Operations (in dollars per share) | 0.07 | 0.23 | 1.20 |
| Net Earnings (in dollars per share) | 0.27 | 0.94 | 2.92 |
| Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) | 1,740 | 1,477 | 1,496 |
| Dilutive Common Stock Options (in shares) | 9 | 6 | 10 |
| Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) | 1,749 | 1,483 | 1,506 |
| Outstanding Common Stock Options Having No Dilutive Effect (in shares) | 5 | 1 | |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |